Global Gene-based Advanced Therapy Medicinal Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
LPI (LP Information)' newest research report, the “Gene-based Advanced Therapy Medicinal Industry Forecast” looks at past sales and reviews total world Gene-based Advanced Therapy Medicinal sales in 2022, providing a comprehensive analysis by region and market sector of projected Gene-based Advanced Therapy Medicinal sales for 2023 through 2029. With Gene-based Advanced Therapy Medicinal sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene-based Advanced Therapy Medicinal industry.
This Insight Report provides a comprehensive analysis of the global Gene-based Advanced Therapy Medicinal landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gene-based Advanced Therapy Medicinal portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene-based Advanced Therapy Medicinal market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene-based Advanced Therapy Medicinal and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene-based Advanced Therapy Medicinal.
The global Gene-based Advanced Therapy Medicinal market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Gene-based Advanced Therapy Medicinal is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Gene-based Advanced Therapy Medicinal is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Gene-based Advanced Therapy Medicinal is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Gene-based Advanced Therapy Medicinal players cover Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics and Sunway Biotech, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Gene-based Advanced Therapy Medicinal market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Gene Delivery System or Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow doctors to treat a disorder by inserting a gene into a patient's cells instead of using drugs or surgery.
LPI (LP Information)' newest research report, the “Gene-based Advanced Therapy Medicinal Industry Forecast” looks at past sales and reviews total world Gene-based Advanced Therapy Medicinal sales in 2022, providing a comprehensive analysis by region and market sector of projected Gene-based Advanced Therapy Medicinal sales for 2023 through 2029. With Gene-based Advanced Therapy Medicinal sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gene-based Advanced Therapy Medicinal industry.
This Insight Report provides a comprehensive analysis of the global Gene-based Advanced Therapy Medicinal landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gene-based Advanced Therapy Medicinal portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gene-based Advanced Therapy Medicinal market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gene-based Advanced Therapy Medicinal and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gene-based Advanced Therapy Medicinal.
The global Gene-based Advanced Therapy Medicinal market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Gene-based Advanced Therapy Medicinal is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Gene-based Advanced Therapy Medicinal is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Gene-based Advanced Therapy Medicinal is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Gene-based Advanced Therapy Medicinal players cover Biogen, Novartis, Gilead Sciences, Sarepta Therapeutics, Alnylam Pharmaceuticals, Amgen, Spark Therapeutics, Akcea Therapeutics and Sunway Biotech, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Gene-based Advanced Therapy Medicinal market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Viral Gene Delivery System
- Non-viral Gene Delivery System
- Neurological Diseases
- Cancer
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Biogen
- Novartis
- Gilead Sciences
- Sarepta Therapeutics
- Alnylam Pharmaceuticals
- Amgen
- Spark Therapeutics
- Akcea Therapeutics
- Sunway Biotech
- SIBIONO
- AnGes
- Orchard Therapeutics
- Human Stem Cells Institute
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gene-based Advanced Therapy Medicinal Market Size 2018-2029
2.1.2 Gene-based Advanced Therapy Medicinal Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Gene-based Advanced Therapy Medicinal Segment by Type
2.2.1 Viral Gene Delivery System
2.2.2 Non-viral Gene Delivery System
2.3 Gene-based Advanced Therapy Medicinal Market Size by Type
2.3.1 Gene-based Advanced Therapy Medicinal Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Gene-based Advanced Therapy Medicinal Market Size Market Share by Type (2018-2023)
2.4 Gene-based Advanced Therapy Medicinal Segment by Application
2.4.1 Neurological Diseases
2.4.2 Cancer
2.4.3 Other
2.5 Gene-based Advanced Therapy Medicinal Market Size by Application
2.5.1 Gene-based Advanced Therapy Medicinal Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Gene-based Advanced Therapy Medicinal Market Size Market Share by Application (2018-2023)
3 GENE-BASED ADVANCED THERAPY MEDICINAL MARKET SIZE BY PLAYER
3.1 Gene-based Advanced Therapy Medicinal Market Size Market Share by Players
3.1.1 Global Gene-based Advanced Therapy Medicinal Revenue by Players (2018-2023)
3.1.2 Global Gene-based Advanced Therapy Medicinal Revenue Market Share by Players (2018-2023)
3.2 Global Gene-based Advanced Therapy Medicinal Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENE-BASED ADVANCED THERAPY MEDICINAL BY REGIONS
4.1 Gene-based Advanced Therapy Medicinal Market Size by Regions (2018-2023)
4.2 Americas Gene-based Advanced Therapy Medicinal Market Size Growth (2018-2023)
4.3 APAC Gene-based Advanced Therapy Medicinal Market Size Growth (2018-2023)
4.4 Europe Gene-based Advanced Therapy Medicinal Market Size Growth (2018-2023)
4.5 Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Gene-based Advanced Therapy Medicinal Market Size by Country (2018-2023)
5.2 Americas Gene-based Advanced Therapy Medicinal Market Size by Type (2018-2023)
5.3 Americas Gene-based Advanced Therapy Medicinal Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gene-based Advanced Therapy Medicinal Market Size by Region (2018-2023)
6.2 APAC Gene-based Advanced Therapy Medicinal Market Size by Type (2018-2023)
6.3 APAC Gene-based Advanced Therapy Medicinal Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gene-based Advanced Therapy Medicinal by Country (2018-2023)
7.2 Europe Gene-based Advanced Therapy Medicinal Market Size by Type (2018-2023)
7.3 Europe Gene-based Advanced Therapy Medicinal Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gene-based Advanced Therapy Medicinal by Region (2018-2023)
8.2 Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size by Type (2018-2023)
8.3 Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENE-BASED ADVANCED THERAPY MEDICINAL MARKET FORECAST
10.1 Global Gene-based Advanced Therapy Medicinal Forecast by Regions (2024-2029)
10.1.1 Global Gene-based Advanced Therapy Medicinal Forecast by Regions (2024-2029)
10.1.2 Americas Gene-based Advanced Therapy Medicinal Forecast
10.1.3 APAC Gene-based Advanced Therapy Medicinal Forecast
10.1.4 Europe Gene-based Advanced Therapy Medicinal Forecast
10.1.5 Middle East & Africa Gene-based Advanced Therapy Medicinal Forecast
10.2 Americas Gene-based Advanced Therapy Medicinal Forecast by Country (2024-2029)
10.2.1 United States Gene-based Advanced Therapy Medicinal Market Forecast
10.2.2 Canada Gene-based Advanced Therapy Medicinal Market Forecast
10.2.3 Mexico Gene-based Advanced Therapy Medicinal Market Forecast
10.2.4 Brazil Gene-based Advanced Therapy Medicinal Market Forecast
10.3 APAC Gene-based Advanced Therapy Medicinal Forecast by Region (2024-2029)
10.3.1 China Gene-based Advanced Therapy Medicinal Market Forecast
10.3.2 Japan Gene-based Advanced Therapy Medicinal Market Forecast
10.3.3 Korea Gene-based Advanced Therapy Medicinal Market Forecast
10.3.4 Southeast Asia Gene-based Advanced Therapy Medicinal Market Forecast
10.3.5 India Gene-based Advanced Therapy Medicinal Market Forecast
10.3.6 Australia Gene-based Advanced Therapy Medicinal Market Forecast
10.4 Europe Gene-based Advanced Therapy Medicinal Forecast by Country (2024-2029)
10.4.1 Germany Gene-based Advanced Therapy Medicinal Market Forecast
10.4.2 France Gene-based Advanced Therapy Medicinal Market Forecast
10.4.3 UK Gene-based Advanced Therapy Medicinal Market Forecast
10.4.4 Italy Gene-based Advanced Therapy Medicinal Market Forecast
10.4.5 Russia Gene-based Advanced Therapy Medicinal Market Forecast
10.5 Middle East & Africa Gene-based Advanced Therapy Medicinal Forecast by Region (2024-2029)
10.5.1 Egypt Gene-based Advanced Therapy Medicinal Market Forecast
10.5.2 South Africa Gene-based Advanced Therapy Medicinal Market Forecast
10.5.3 Israel Gene-based Advanced Therapy Medicinal Market Forecast
10.5.4 Turkey Gene-based Advanced Therapy Medicinal Market Forecast
10.5.5 GCC Countries Gene-based Advanced Therapy Medicinal Market Forecast
10.6 Global Gene-based Advanced Therapy Medicinal Forecast by Type (2024-2029)
10.7 Global Gene-based Advanced Therapy Medicinal Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Biogen
11.1.1 Biogen Company Information
11.1.2 Biogen Gene-based Advanced Therapy Medicinal Product Offered
11.1.3 Biogen Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Biogen Main Business Overview
11.1.5 Biogen Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Gene-based Advanced Therapy Medicinal Product Offered
11.2.3 Novartis Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Information
11.3.2 Gilead Sciences Gene-based Advanced Therapy Medicinal Product Offered
11.3.3 Gilead Sciences Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Gilead Sciences Main Business Overview
11.3.5 Gilead Sciences Latest Developments
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Information
11.4.2 Sarepta Therapeutics Gene-based Advanced Therapy Medicinal Product Offered
11.4.3 Sarepta Therapeutics Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Sarepta Therapeutics Main Business Overview
11.4.5 Sarepta Therapeutics Latest Developments
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Information
11.5.2 Alnylam Pharmaceuticals Gene-based Advanced Therapy Medicinal Product Offered
11.5.3 Alnylam Pharmaceuticals Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Alnylam Pharmaceuticals Main Business Overview
11.5.5 Alnylam Pharmaceuticals Latest Developments
11.6 Amgen
11.6.1 Amgen Company Information
11.6.2 Amgen Gene-based Advanced Therapy Medicinal Product Offered
11.6.3 Amgen Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Amgen Main Business Overview
11.6.5 Amgen Latest Developments
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Information
11.7.2 Spark Therapeutics Gene-based Advanced Therapy Medicinal Product Offered
11.7.3 Spark Therapeutics Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Spark Therapeutics Main Business Overview
11.7.5 Spark Therapeutics Latest Developments
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Information
11.8.2 Akcea Therapeutics Gene-based Advanced Therapy Medicinal Product Offered
11.8.3 Akcea Therapeutics Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Akcea Therapeutics Main Business Overview
11.8.5 Akcea Therapeutics Latest Developments
11.9 Sunway Biotech
11.9.1 Sunway Biotech Company Information
11.9.2 Sunway Biotech Gene-based Advanced Therapy Medicinal Product Offered
11.9.3 Sunway Biotech Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Sunway Biotech Main Business Overview
11.9.5 Sunway Biotech Latest Developments
11.10 SIBIONO
11.10.1 SIBIONO Company Information
11.10.2 SIBIONO Gene-based Advanced Therapy Medicinal Product Offered
11.10.3 SIBIONO Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 SIBIONO Main Business Overview
11.10.5 SIBIONO Latest Developments
11.11 AnGes
11.11.1 AnGes Company Information
11.11.2 AnGes Gene-based Advanced Therapy Medicinal Product Offered
11.11.3 AnGes Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 AnGes Main Business Overview
11.11.5 AnGes Latest Developments
11.12 Orchard Therapeutics
11.12.1 Orchard Therapeutics Company Information
11.12.2 Orchard Therapeutics Gene-based Advanced Therapy Medicinal Product Offered
11.12.3 Orchard Therapeutics Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Orchard Therapeutics Main Business Overview
11.12.5 Orchard Therapeutics Latest Developments
11.13 Human Stem Cells Institute
11.13.1 Human Stem Cells Institute Company Information
11.13.2 Human Stem Cells Institute Gene-based Advanced Therapy Medicinal Product Offered
11.13.3 Human Stem Cells Institute Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Human Stem Cells Institute Main Business Overview
11.13.5 Human Stem Cells Institute Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gene-based Advanced Therapy Medicinal Market Size 2018-2029
2.1.2 Gene-based Advanced Therapy Medicinal Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Gene-based Advanced Therapy Medicinal Segment by Type
2.2.1 Viral Gene Delivery System
2.2.2 Non-viral Gene Delivery System
2.3 Gene-based Advanced Therapy Medicinal Market Size by Type
2.3.1 Gene-based Advanced Therapy Medicinal Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Gene-based Advanced Therapy Medicinal Market Size Market Share by Type (2018-2023)
2.4 Gene-based Advanced Therapy Medicinal Segment by Application
2.4.1 Neurological Diseases
2.4.2 Cancer
2.4.3 Other
2.5 Gene-based Advanced Therapy Medicinal Market Size by Application
2.5.1 Gene-based Advanced Therapy Medicinal Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Gene-based Advanced Therapy Medicinal Market Size Market Share by Application (2018-2023)
3 GENE-BASED ADVANCED THERAPY MEDICINAL MARKET SIZE BY PLAYER
3.1 Gene-based Advanced Therapy Medicinal Market Size Market Share by Players
3.1.1 Global Gene-based Advanced Therapy Medicinal Revenue by Players (2018-2023)
3.1.2 Global Gene-based Advanced Therapy Medicinal Revenue Market Share by Players (2018-2023)
3.2 Global Gene-based Advanced Therapy Medicinal Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 GENE-BASED ADVANCED THERAPY MEDICINAL BY REGIONS
4.1 Gene-based Advanced Therapy Medicinal Market Size by Regions (2018-2023)
4.2 Americas Gene-based Advanced Therapy Medicinal Market Size Growth (2018-2023)
4.3 APAC Gene-based Advanced Therapy Medicinal Market Size Growth (2018-2023)
4.4 Europe Gene-based Advanced Therapy Medicinal Market Size Growth (2018-2023)
4.5 Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Gene-based Advanced Therapy Medicinal Market Size by Country (2018-2023)
5.2 Americas Gene-based Advanced Therapy Medicinal Market Size by Type (2018-2023)
5.3 Americas Gene-based Advanced Therapy Medicinal Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gene-based Advanced Therapy Medicinal Market Size by Region (2018-2023)
6.2 APAC Gene-based Advanced Therapy Medicinal Market Size by Type (2018-2023)
6.3 APAC Gene-based Advanced Therapy Medicinal Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Gene-based Advanced Therapy Medicinal by Country (2018-2023)
7.2 Europe Gene-based Advanced Therapy Medicinal Market Size by Type (2018-2023)
7.3 Europe Gene-based Advanced Therapy Medicinal Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gene-based Advanced Therapy Medicinal by Region (2018-2023)
8.2 Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size by Type (2018-2023)
8.3 Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL GENE-BASED ADVANCED THERAPY MEDICINAL MARKET FORECAST
10.1 Global Gene-based Advanced Therapy Medicinal Forecast by Regions (2024-2029)
10.1.1 Global Gene-based Advanced Therapy Medicinal Forecast by Regions (2024-2029)
10.1.2 Americas Gene-based Advanced Therapy Medicinal Forecast
10.1.3 APAC Gene-based Advanced Therapy Medicinal Forecast
10.1.4 Europe Gene-based Advanced Therapy Medicinal Forecast
10.1.5 Middle East & Africa Gene-based Advanced Therapy Medicinal Forecast
10.2 Americas Gene-based Advanced Therapy Medicinal Forecast by Country (2024-2029)
10.2.1 United States Gene-based Advanced Therapy Medicinal Market Forecast
10.2.2 Canada Gene-based Advanced Therapy Medicinal Market Forecast
10.2.3 Mexico Gene-based Advanced Therapy Medicinal Market Forecast
10.2.4 Brazil Gene-based Advanced Therapy Medicinal Market Forecast
10.3 APAC Gene-based Advanced Therapy Medicinal Forecast by Region (2024-2029)
10.3.1 China Gene-based Advanced Therapy Medicinal Market Forecast
10.3.2 Japan Gene-based Advanced Therapy Medicinal Market Forecast
10.3.3 Korea Gene-based Advanced Therapy Medicinal Market Forecast
10.3.4 Southeast Asia Gene-based Advanced Therapy Medicinal Market Forecast
10.3.5 India Gene-based Advanced Therapy Medicinal Market Forecast
10.3.6 Australia Gene-based Advanced Therapy Medicinal Market Forecast
10.4 Europe Gene-based Advanced Therapy Medicinal Forecast by Country (2024-2029)
10.4.1 Germany Gene-based Advanced Therapy Medicinal Market Forecast
10.4.2 France Gene-based Advanced Therapy Medicinal Market Forecast
10.4.3 UK Gene-based Advanced Therapy Medicinal Market Forecast
10.4.4 Italy Gene-based Advanced Therapy Medicinal Market Forecast
10.4.5 Russia Gene-based Advanced Therapy Medicinal Market Forecast
10.5 Middle East & Africa Gene-based Advanced Therapy Medicinal Forecast by Region (2024-2029)
10.5.1 Egypt Gene-based Advanced Therapy Medicinal Market Forecast
10.5.2 South Africa Gene-based Advanced Therapy Medicinal Market Forecast
10.5.3 Israel Gene-based Advanced Therapy Medicinal Market Forecast
10.5.4 Turkey Gene-based Advanced Therapy Medicinal Market Forecast
10.5.5 GCC Countries Gene-based Advanced Therapy Medicinal Market Forecast
10.6 Global Gene-based Advanced Therapy Medicinal Forecast by Type (2024-2029)
10.7 Global Gene-based Advanced Therapy Medicinal Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Biogen
11.1.1 Biogen Company Information
11.1.2 Biogen Gene-based Advanced Therapy Medicinal Product Offered
11.1.3 Biogen Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Biogen Main Business Overview
11.1.5 Biogen Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Gene-based Advanced Therapy Medicinal Product Offered
11.2.3 Novartis Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Information
11.3.2 Gilead Sciences Gene-based Advanced Therapy Medicinal Product Offered
11.3.3 Gilead Sciences Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Gilead Sciences Main Business Overview
11.3.5 Gilead Sciences Latest Developments
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Information
11.4.2 Sarepta Therapeutics Gene-based Advanced Therapy Medicinal Product Offered
11.4.3 Sarepta Therapeutics Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Sarepta Therapeutics Main Business Overview
11.4.5 Sarepta Therapeutics Latest Developments
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Information
11.5.2 Alnylam Pharmaceuticals Gene-based Advanced Therapy Medicinal Product Offered
11.5.3 Alnylam Pharmaceuticals Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Alnylam Pharmaceuticals Main Business Overview
11.5.5 Alnylam Pharmaceuticals Latest Developments
11.6 Amgen
11.6.1 Amgen Company Information
11.6.2 Amgen Gene-based Advanced Therapy Medicinal Product Offered
11.6.3 Amgen Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Amgen Main Business Overview
11.6.5 Amgen Latest Developments
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Information
11.7.2 Spark Therapeutics Gene-based Advanced Therapy Medicinal Product Offered
11.7.3 Spark Therapeutics Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Spark Therapeutics Main Business Overview
11.7.5 Spark Therapeutics Latest Developments
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Information
11.8.2 Akcea Therapeutics Gene-based Advanced Therapy Medicinal Product Offered
11.8.3 Akcea Therapeutics Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Akcea Therapeutics Main Business Overview
11.8.5 Akcea Therapeutics Latest Developments
11.9 Sunway Biotech
11.9.1 Sunway Biotech Company Information
11.9.2 Sunway Biotech Gene-based Advanced Therapy Medicinal Product Offered
11.9.3 Sunway Biotech Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Sunway Biotech Main Business Overview
11.9.5 Sunway Biotech Latest Developments
11.10 SIBIONO
11.10.1 SIBIONO Company Information
11.10.2 SIBIONO Gene-based Advanced Therapy Medicinal Product Offered
11.10.3 SIBIONO Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 SIBIONO Main Business Overview
11.10.5 SIBIONO Latest Developments
11.11 AnGes
11.11.1 AnGes Company Information
11.11.2 AnGes Gene-based Advanced Therapy Medicinal Product Offered
11.11.3 AnGes Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 AnGes Main Business Overview
11.11.5 AnGes Latest Developments
11.12 Orchard Therapeutics
11.12.1 Orchard Therapeutics Company Information
11.12.2 Orchard Therapeutics Gene-based Advanced Therapy Medicinal Product Offered
11.12.3 Orchard Therapeutics Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Orchard Therapeutics Main Business Overview
11.12.5 Orchard Therapeutics Latest Developments
11.13 Human Stem Cells Institute
11.13.1 Human Stem Cells Institute Company Information
11.13.2 Human Stem Cells Institute Gene-based Advanced Therapy Medicinal Product Offered
11.13.3 Human Stem Cells Institute Gene-based Advanced Therapy Medicinal Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 Human Stem Cells Institute Main Business Overview
11.13.5 Human Stem Cells Institute Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Gene-based Advanced Therapy Medicinal Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Viral Gene Delivery System
Table 3. Major Players of Non-viral Gene Delivery System
Table 4. Gene-based Advanced Therapy Medicinal Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Gene-based Advanced Therapy Medicinal Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Gene-based Advanced Therapy Medicinal Market Size Market Share by Type (2018-2023)
Table 7. Gene-based Advanced Therapy Medicinal Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Gene-based Advanced Therapy Medicinal Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Gene-based Advanced Therapy Medicinal Market Size Market Share by Application (2018-2023)
Table 10. Global Gene-based Advanced Therapy Medicinal Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Gene-based Advanced Therapy Medicinal Revenue Market Share by Player (2018-2023)
Table 12. Gene-based Advanced Therapy Medicinal Key Players Head office and Products Offered
Table 13. Gene-based Advanced Therapy Medicinal Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Gene-based Advanced Therapy Medicinal Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Gene-based Advanced Therapy Medicinal Market Size Market Share by Regions (2018-2023)
Table 18. Global Gene-based Advanced Therapy Medicinal Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Gene-based Advanced Therapy Medicinal Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Gene-based Advanced Therapy Medicinal Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Gene-based Advanced Therapy Medicinal Market Size Market Share by Country (2018-2023)
Table 22. Americas Gene-based Advanced Therapy Medicinal Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Gene-based Advanced Therapy Medicinal Market Size Market Share by Type (2018-2023)
Table 24. Americas Gene-based Advanced Therapy Medicinal Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Gene-based Advanced Therapy Medicinal Market Size Market Share by Application (2018-2023)
Table 26. APAC Gene-based Advanced Therapy Medicinal Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Gene-based Advanced Therapy Medicinal Market Size Market Share by Region (2018-2023)
Table 28. APAC Gene-based Advanced Therapy Medicinal Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Gene-based Advanced Therapy Medicinal Market Size Market Share by Type (2018-2023)
Table 30. APAC Gene-based Advanced Therapy Medicinal Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Gene-based Advanced Therapy Medicinal Market Size Market Share by Application (2018-2023)
Table 32. Europe Gene-based Advanced Therapy Medicinal Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Gene-based Advanced Therapy Medicinal Market Size Market Share by Country (2018-2023)
Table 34. Europe Gene-based Advanced Therapy Medicinal Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Gene-based Advanced Therapy Medicinal Market Size Market Share by Type (2018-2023)
Table 36. Europe Gene-based Advanced Therapy Medicinal Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Gene-based Advanced Therapy Medicinal Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Gene-based Advanced Therapy Medicinal
Table 45. Key Market Challenges & Risks of Gene-based Advanced Therapy Medicinal
Table 46. Key Industry Trends of Gene-based Advanced Therapy Medicinal
Table 47. Global Gene-based Advanced Therapy Medicinal Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Gene-based Advanced Therapy Medicinal Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Gene-based Advanced Therapy Medicinal Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Gene-based Advanced Therapy Medicinal Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Biogen Details, Company Type, Gene-based Advanced Therapy Medicinal Area Served and Its Competitors
Table 52. Biogen Gene-based Advanced Therapy Medicinal Product Offered
Table 53. Biogen Gene-based Advanced Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Biogen Main Business
Table 55. Biogen Latest Developments
Table 56. Novartis Details, Company Type, Gene-based Advanced Therapy Medicinal Area Served and Its Competitors
Table 57. Novartis Gene-based Advanced Therapy Medicinal Product Offered
Table 58. Novartis Main Business
Table 59. Novartis Gene-based Advanced Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Novartis Latest Developments
Table 61. Gilead Sciences Details, Company Type, Gene-based Advanced Therapy Medicinal Area Served and Its Competitors
Table 62. Gilead Sciences Gene-based Advanced Therapy Medicinal Product Offered
Table 63. Gilead Sciences Main Business
Table 64. Gilead Sciences Gene-based Advanced Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Gilead Sciences Latest Developments
Table 66. Sarepta Therapeutics Details, Company Type, Gene-based Advanced Therapy Medicinal Area Served and Its Competitors
Table 67. Sarepta Therapeutics Gene-based Advanced Therapy Medicinal Product Offered
Table 68. Sarepta Therapeutics Main Business
Table 69. Sarepta Therapeutics Gene-based Advanced Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Sarepta Therapeutics Latest Developments
Table 71. Alnylam Pharmaceuticals Details, Company Type, Gene-based Advanced Therapy Medicinal Area Served and Its Competitors
Table 72. Alnylam Pharmaceuticals Gene-based Advanced Therapy Medicinal Product Offered
Table 73. Alnylam Pharmaceuticals Main Business
Table 74. Alnylam Pharmaceuticals Gene-based Advanced Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Alnylam Pharmaceuticals Latest Developments
Table 76. Amgen Details, Company Type, Gene-based Advanced Therapy Medicinal Area Served and Its Competitors
Table 77. Amgen Gene-based Advanced Therapy Medicinal Product Offered
Table 78. Amgen Main Business
Table 79. Amgen Gene-based Advanced Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Amgen Latest Developments
Table 81. Spark Therapeutics Details, Company Type, Gene-based Advanced Therapy Medicinal Area Served and Its Competitors
Table 82. Spark Therapeutics Gene-based Advanced Therapy Medicinal Product Offered
Table 83. Spark Therapeutics Main Business
Table 84. Spark Therapeutics Gene-based Advanced Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Spark Therapeutics Latest Developments
Table 86. Akcea Therapeutics Details, Company Type, Gene-based Advanced Therapy Medicinal Area Served and Its Competitors
Table 87. Akcea Therapeutics Gene-based Advanced Therapy Medicinal Product Offered
Table 88. Akcea Therapeutics Main Business
Table 89. Akcea Therapeutics Gene-based Advanced Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Akcea Therapeutics Latest Developments
Table 91. Sunway Biotech Details, Company Type, Gene-based Advanced Therapy Medicinal Area Served and Its Competitors
Table 92. Sunway Biotech Gene-based Advanced Therapy Medicinal Product Offered
Table 93. Sunway Biotech Main Business
Table 94. Sunway Biotech Gene-based Advanced Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Sunway Biotech Latest Developments
Table 96. SIBIONO Details, Company Type, Gene-based Advanced Therapy Medicinal Area Served and Its Competitors
Table 97. SIBIONO Gene-based Advanced Therapy Medicinal Product Offered
Table 98. SIBIONO Main Business
Table 99. SIBIONO Gene-based Advanced Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. SIBIONO Latest Developments
Table 101. AnGes Details, Company Type, Gene-based Advanced Therapy Medicinal Area Served and Its Competitors
Table 102. AnGes Gene-based Advanced Therapy Medicinal Product Offered
Table 103. AnGes Gene-based Advanced Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. AnGes Main Business
Table 105. AnGes Latest Developments
Table 106. Orchard Therapeutics Details, Company Type, Gene-based Advanced Therapy Medicinal Area Served and Its Competitors
Table 107. Orchard Therapeutics Gene-based Advanced Therapy Medicinal Product Offered
Table 108. Orchard Therapeutics Main Business
Table 109. Orchard Therapeutics Gene-based Advanced Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. Orchard Therapeutics Latest Developments
Table 111. Human Stem Cells Institute Details, Company Type, Gene-based Advanced Therapy Medicinal Area Served and Its Competitors
Table 112. Human Stem Cells Institute Gene-based Advanced Therapy Medicinal Product Offered
Table 113. Human Stem Cells Institute Main Business
Table 114. Human Stem Cells Institute Gene-based Advanced Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. Human Stem Cells Institute Latest Developments
Table 1. Gene-based Advanced Therapy Medicinal Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Viral Gene Delivery System
Table 3. Major Players of Non-viral Gene Delivery System
Table 4. Gene-based Advanced Therapy Medicinal Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Gene-based Advanced Therapy Medicinal Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Gene-based Advanced Therapy Medicinal Market Size Market Share by Type (2018-2023)
Table 7. Gene-based Advanced Therapy Medicinal Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Gene-based Advanced Therapy Medicinal Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Gene-based Advanced Therapy Medicinal Market Size Market Share by Application (2018-2023)
Table 10. Global Gene-based Advanced Therapy Medicinal Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Gene-based Advanced Therapy Medicinal Revenue Market Share by Player (2018-2023)
Table 12. Gene-based Advanced Therapy Medicinal Key Players Head office and Products Offered
Table 13. Gene-based Advanced Therapy Medicinal Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Gene-based Advanced Therapy Medicinal Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Gene-based Advanced Therapy Medicinal Market Size Market Share by Regions (2018-2023)
Table 18. Global Gene-based Advanced Therapy Medicinal Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Gene-based Advanced Therapy Medicinal Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Gene-based Advanced Therapy Medicinal Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Gene-based Advanced Therapy Medicinal Market Size Market Share by Country (2018-2023)
Table 22. Americas Gene-based Advanced Therapy Medicinal Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Gene-based Advanced Therapy Medicinal Market Size Market Share by Type (2018-2023)
Table 24. Americas Gene-based Advanced Therapy Medicinal Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Gene-based Advanced Therapy Medicinal Market Size Market Share by Application (2018-2023)
Table 26. APAC Gene-based Advanced Therapy Medicinal Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Gene-based Advanced Therapy Medicinal Market Size Market Share by Region (2018-2023)
Table 28. APAC Gene-based Advanced Therapy Medicinal Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Gene-based Advanced Therapy Medicinal Market Size Market Share by Type (2018-2023)
Table 30. APAC Gene-based Advanced Therapy Medicinal Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Gene-based Advanced Therapy Medicinal Market Size Market Share by Application (2018-2023)
Table 32. Europe Gene-based Advanced Therapy Medicinal Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Gene-based Advanced Therapy Medicinal Market Size Market Share by Country (2018-2023)
Table 34. Europe Gene-based Advanced Therapy Medicinal Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Gene-based Advanced Therapy Medicinal Market Size Market Share by Type (2018-2023)
Table 36. Europe Gene-based Advanced Therapy Medicinal Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Gene-based Advanced Therapy Medicinal Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Gene-based Advanced Therapy Medicinal
Table 45. Key Market Challenges & Risks of Gene-based Advanced Therapy Medicinal
Table 46. Key Industry Trends of Gene-based Advanced Therapy Medicinal
Table 47. Global Gene-based Advanced Therapy Medicinal Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Gene-based Advanced Therapy Medicinal Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Gene-based Advanced Therapy Medicinal Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Gene-based Advanced Therapy Medicinal Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Biogen Details, Company Type, Gene-based Advanced Therapy Medicinal Area Served and Its Competitors
Table 52. Biogen Gene-based Advanced Therapy Medicinal Product Offered
Table 53. Biogen Gene-based Advanced Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Biogen Main Business
Table 55. Biogen Latest Developments
Table 56. Novartis Details, Company Type, Gene-based Advanced Therapy Medicinal Area Served and Its Competitors
Table 57. Novartis Gene-based Advanced Therapy Medicinal Product Offered
Table 58. Novartis Main Business
Table 59. Novartis Gene-based Advanced Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Novartis Latest Developments
Table 61. Gilead Sciences Details, Company Type, Gene-based Advanced Therapy Medicinal Area Served and Its Competitors
Table 62. Gilead Sciences Gene-based Advanced Therapy Medicinal Product Offered
Table 63. Gilead Sciences Main Business
Table 64. Gilead Sciences Gene-based Advanced Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Gilead Sciences Latest Developments
Table 66. Sarepta Therapeutics Details, Company Type, Gene-based Advanced Therapy Medicinal Area Served and Its Competitors
Table 67. Sarepta Therapeutics Gene-based Advanced Therapy Medicinal Product Offered
Table 68. Sarepta Therapeutics Main Business
Table 69. Sarepta Therapeutics Gene-based Advanced Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Sarepta Therapeutics Latest Developments
Table 71. Alnylam Pharmaceuticals Details, Company Type, Gene-based Advanced Therapy Medicinal Area Served and Its Competitors
Table 72. Alnylam Pharmaceuticals Gene-based Advanced Therapy Medicinal Product Offered
Table 73. Alnylam Pharmaceuticals Main Business
Table 74. Alnylam Pharmaceuticals Gene-based Advanced Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Alnylam Pharmaceuticals Latest Developments
Table 76. Amgen Details, Company Type, Gene-based Advanced Therapy Medicinal Area Served and Its Competitors
Table 77. Amgen Gene-based Advanced Therapy Medicinal Product Offered
Table 78. Amgen Main Business
Table 79. Amgen Gene-based Advanced Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Amgen Latest Developments
Table 81. Spark Therapeutics Details, Company Type, Gene-based Advanced Therapy Medicinal Area Served and Its Competitors
Table 82. Spark Therapeutics Gene-based Advanced Therapy Medicinal Product Offered
Table 83. Spark Therapeutics Main Business
Table 84. Spark Therapeutics Gene-based Advanced Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Spark Therapeutics Latest Developments
Table 86. Akcea Therapeutics Details, Company Type, Gene-based Advanced Therapy Medicinal Area Served and Its Competitors
Table 87. Akcea Therapeutics Gene-based Advanced Therapy Medicinal Product Offered
Table 88. Akcea Therapeutics Main Business
Table 89. Akcea Therapeutics Gene-based Advanced Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Akcea Therapeutics Latest Developments
Table 91. Sunway Biotech Details, Company Type, Gene-based Advanced Therapy Medicinal Area Served and Its Competitors
Table 92. Sunway Biotech Gene-based Advanced Therapy Medicinal Product Offered
Table 93. Sunway Biotech Main Business
Table 94. Sunway Biotech Gene-based Advanced Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 95. Sunway Biotech Latest Developments
Table 96. SIBIONO Details, Company Type, Gene-based Advanced Therapy Medicinal Area Served and Its Competitors
Table 97. SIBIONO Gene-based Advanced Therapy Medicinal Product Offered
Table 98. SIBIONO Main Business
Table 99. SIBIONO Gene-based Advanced Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 100. SIBIONO Latest Developments
Table 101. AnGes Details, Company Type, Gene-based Advanced Therapy Medicinal Area Served and Its Competitors
Table 102. AnGes Gene-based Advanced Therapy Medicinal Product Offered
Table 103. AnGes Gene-based Advanced Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 104. AnGes Main Business
Table 105. AnGes Latest Developments
Table 106. Orchard Therapeutics Details, Company Type, Gene-based Advanced Therapy Medicinal Area Served and Its Competitors
Table 107. Orchard Therapeutics Gene-based Advanced Therapy Medicinal Product Offered
Table 108. Orchard Therapeutics Main Business
Table 109. Orchard Therapeutics Gene-based Advanced Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 110. Orchard Therapeutics Latest Developments
Table 111. Human Stem Cells Institute Details, Company Type, Gene-based Advanced Therapy Medicinal Area Served and Its Competitors
Table 112. Human Stem Cells Institute Gene-based Advanced Therapy Medicinal Product Offered
Table 113. Human Stem Cells Institute Main Business
Table 114. Human Stem Cells Institute Gene-based Advanced Therapy Medicinal Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 115. Human Stem Cells Institute Latest Developments
LIST OF FIGURES
Figure 1. Gene-based Advanced Therapy Medicinal Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gene-based Advanced Therapy Medicinal Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Gene-based Advanced Therapy Medicinal Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Gene-based Advanced Therapy Medicinal Sales Market Share by Country/Region (2022)
Figure 8. Gene-based Advanced Therapy Medicinal Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Gene-based Advanced Therapy Medicinal Market Size Market Share by Type in 2022
Figure 10. Gene-based Advanced Therapy Medicinal in Neurological Diseases
Figure 11. Global Gene-based Advanced Therapy Medicinal Market: Neurological Diseases (2018-2023) & ($ Millions)
Figure 12. Gene-based Advanced Therapy Medicinal in Cancer
Figure 13. Global Gene-based Advanced Therapy Medicinal Market: Cancer (2018-2023) & ($ Millions)
Figure 14. Gene-based Advanced Therapy Medicinal in Other
Figure 15. Global Gene-based Advanced Therapy Medicinal Market: Other (2018-2023) & ($ Millions)
Figure 16. Global Gene-based Advanced Therapy Medicinal Market Size Market Share by Application in 2022
Figure 17. Global Gene-based Advanced Therapy Medicinal Revenue Market Share by Player in 2022
Figure 18. Global Gene-based Advanced Therapy Medicinal Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Gene-based Advanced Therapy Medicinal Market Size 2018-2023 ($ Millions)
Figure 20. APAC Gene-based Advanced Therapy Medicinal Market Size 2018-2023 ($ Millions)
Figure 21. Europe Gene-based Advanced Therapy Medicinal Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size 2018-2023 ($ Millions)
Figure 23. Americas Gene-based Advanced Therapy Medicinal Value Market Share by Country in 2022
Figure 24. United States Gene-based Advanced Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Gene-based Advanced Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Gene-based Advanced Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Gene-based Advanced Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Gene-based Advanced Therapy Medicinal Market Size Market Share by Region in 2022
Figure 29. APAC Gene-based Advanced Therapy Medicinal Market Size Market Share by Type in 2022
Figure 30. APAC Gene-based Advanced Therapy Medicinal Market Size Market Share by Application in 2022
Figure 31. China Gene-based Advanced Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Gene-based Advanced Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Gene-based Advanced Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Gene-based Advanced Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Gene-based Advanced Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Gene-based Advanced Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Gene-based Advanced Therapy Medicinal Market Size Market Share by Country in 2022
Figure 38. Europe Gene-based Advanced Therapy Medicinal Market Size Market Share by Type (2018-2023)
Figure 39. Europe Gene-based Advanced Therapy Medicinal Market Size Market Share by Application (2018-2023)
Figure 40. Germany Gene-based Advanced Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Gene-based Advanced Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Gene-based Advanced Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Gene-based Advanced Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Gene-based Advanced Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Gene-based Advanced Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Gene-based Advanced Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Gene-based Advanced Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Gene-based Advanced Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Gene-based Advanced Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 54. APAC Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 55. Europe Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 57. United States Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 58. Canada Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 61. China Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 62. Japan Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 63. Korea Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 65. India Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 66. Australia Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 67. Germany Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 68. France Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 69. UK Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 70. Italy Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 71. Russia Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 72. Spain Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 75. Israel Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 78. Global Gene-based Advanced Therapy Medicinal Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Gene-based Advanced Therapy Medicinal Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Gene-based Advanced Therapy Medicinal Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Gene-based Advanced Therapy Medicinal Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Gene-based Advanced Therapy Medicinal Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Gene-based Advanced Therapy Medicinal Sales Market Share by Country/Region (2022)
Figure 8. Gene-based Advanced Therapy Medicinal Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Gene-based Advanced Therapy Medicinal Market Size Market Share by Type in 2022
Figure 10. Gene-based Advanced Therapy Medicinal in Neurological Diseases
Figure 11. Global Gene-based Advanced Therapy Medicinal Market: Neurological Diseases (2018-2023) & ($ Millions)
Figure 12. Gene-based Advanced Therapy Medicinal in Cancer
Figure 13. Global Gene-based Advanced Therapy Medicinal Market: Cancer (2018-2023) & ($ Millions)
Figure 14. Gene-based Advanced Therapy Medicinal in Other
Figure 15. Global Gene-based Advanced Therapy Medicinal Market: Other (2018-2023) & ($ Millions)
Figure 16. Global Gene-based Advanced Therapy Medicinal Market Size Market Share by Application in 2022
Figure 17. Global Gene-based Advanced Therapy Medicinal Revenue Market Share by Player in 2022
Figure 18. Global Gene-based Advanced Therapy Medicinal Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Gene-based Advanced Therapy Medicinal Market Size 2018-2023 ($ Millions)
Figure 20. APAC Gene-based Advanced Therapy Medicinal Market Size 2018-2023 ($ Millions)
Figure 21. Europe Gene-based Advanced Therapy Medicinal Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size 2018-2023 ($ Millions)
Figure 23. Americas Gene-based Advanced Therapy Medicinal Value Market Share by Country in 2022
Figure 24. United States Gene-based Advanced Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Gene-based Advanced Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Gene-based Advanced Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Gene-based Advanced Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Gene-based Advanced Therapy Medicinal Market Size Market Share by Region in 2022
Figure 29. APAC Gene-based Advanced Therapy Medicinal Market Size Market Share by Type in 2022
Figure 30. APAC Gene-based Advanced Therapy Medicinal Market Size Market Share by Application in 2022
Figure 31. China Gene-based Advanced Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Gene-based Advanced Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Gene-based Advanced Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Gene-based Advanced Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Gene-based Advanced Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Gene-based Advanced Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Gene-based Advanced Therapy Medicinal Market Size Market Share by Country in 2022
Figure 38. Europe Gene-based Advanced Therapy Medicinal Market Size Market Share by Type (2018-2023)
Figure 39. Europe Gene-based Advanced Therapy Medicinal Market Size Market Share by Application (2018-2023)
Figure 40. Germany Gene-based Advanced Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Gene-based Advanced Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Gene-based Advanced Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Gene-based Advanced Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Gene-based Advanced Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Gene-based Advanced Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Gene-based Advanced Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Gene-based Advanced Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Gene-based Advanced Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Gene-based Advanced Therapy Medicinal Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 54. APAC Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 55. Europe Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 57. United States Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 58. Canada Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 61. China Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 62. Japan Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 63. Korea Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 65. India Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 66. Australia Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 67. Germany Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 68. France Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 69. UK Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 70. Italy Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 71. Russia Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 72. Spain Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 75. Israel Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Gene-based Advanced Therapy Medicinal Market Size 2024-2029 ($ Millions)
Figure 78. Global Gene-based Advanced Therapy Medicinal Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Gene-based Advanced Therapy Medicinal Market Size Market Share Forecast by Application (2024-2029)
